CAS: 1492952-76-7 - 3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-5-(1H-pyrazol-3-yl)-
![3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-5-(1H…](https://static.cymitquimica.com/products/IN/thumb/DA001LJ6.jpg)
3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-5-(1H-pyrazol-3-yl)-
CAS:1492952-76-7
Formula:
C20H18ClF2N5O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
449.8384
Ref: IN-DA001LJ6
| 1g | To inquire | ||
| 5mg | 162.00 € | ||
| 50mg | 160.00 € | ||
| 100mg | 270.00 € | ||
| 250mg | 606.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 4Z-A-330002
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 4Z-A-330001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Asciminib
CAS:1492952-76-7
Asciminib (ABL001) (ABL001) is a potent and selective Bcr-Abl inhibitor (Kd: 0.5-0.8nM).
Formula:
C20H18ClF2N5O3
Purity:
97.93% - 99.45%
Color and Shape:
Solid
Molecular weight:
449.84
Ref: TM-T5177
| 1mg | 62.00 € | ||
| 2mg | 90.00 € | ||
| 5mg | 124.00 € | ||
| 10mg | 183.00 € | ||
| 25mg | 300.00 € | ||
| 50mg | 418.00 € | ||
| 100mg | 618.00 € | ||
| 500mg | 1,291.00 € | ||
| 1mL*10mM (DMSO) | 139.00 € |
Estimated delivery in United States, on Friday 13 Dec 2024
Asciminib
CAS:1492952-76-7
BCR-ABL tyrosine kinase inhibitor; antineoplastic
Formula:
C20H18ClF2N5O3
Purity:
Min. 95%
Molecular weight:
449.84 g/mol
Ref: 3D-BA166957
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire |
Estimated delivery in United States, on Friday 17 Jan 2025
